YARROW BIOSCIENCE, INC. Shareholders' Equity
YARROW BIOSCIENCE, INC. (YARW) had Shareholders' Equity of $22.06 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $22.06M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $24.64M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $27.77M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $38.88M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $22.06M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $24.64M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $27.77M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $38.88M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $44.13M 10-Q · filed 2026-08-13 | $44.13M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $52.09M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $63.54M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $74.87M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $83.37M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $88.73M S-4/A · filed 2026-06-03 | |
| 2023-09-30 | $11.51M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $17.27M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $26.43M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $31.20M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $40.07M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $48.36M 10-Q · filed 2023-11-13 | $48.36M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $55.73M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $48.64M 10-K · filed 2024-03-01 | |
| 2021-09-30 | $58.89M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $74.89M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $92.90M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $37.49M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $49.52M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $71.53M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $69.53M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $17.57M 10-K · filed 2022-03-17 | $68.51M 10-K · filed 2020-03-03 |
| 2019-09-30 | $53.53M 10-Q · filed 2020-11-05 | $87.00M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $60.38M 10-Q · filed 2020-11-05 | $102.18M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $78.00M 10-Q · filed 2020-08-06 | $115.63M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $92.18M 10-K · filed 2021-03-04 | $130.38M 10-K · filed 2019-02-28 |
| 2018-09-30 | $146.88M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $158.19M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $165.70M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $68.60M 10-K · filed 2021-03-04 | -$57.03M 10-K · filed 2018-03-28 |
| 2016-12-31 | -$29.44M 10-K · filed 2020-03-03 | |
| 2015-12-31 | -$15.95M 10-K · filed 2019-02-28 | |
| 2014-12-31 | -$11.41M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |